<?xml version="1.0" encoding="UTF-8"?>
<ref id="b110-ir-2019-09155">
 <label>110</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Cerva</surname>
    <given-names>C</given-names>
   </name>
   <name>
    <surname>Colagrossi</surname>
    <given-names>L</given-names>
   </name>
   <name>
    <surname>Maffongelli</surname>
    <given-names>G</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Persistent risk of HBV reactivation despite extensive lamivudine prophylaxis in haematopoietic stem cell transplant recipients who are anti-HBc-positive or HBV-negative recipients with an antiHBc-positive donor</article-title>
  <source>Clin Microbiol Infect</source>
  <year>2016</year>
  <volume>22</volume>
  <fpage>946</fpage>
  <comment>e1-946.e8</comment>
 </element-citation>
</ref>
